Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Chapter, a technology company based in New York City, said it tripled its revenue last year by filling a market niche designing technology for seniors—specifically, those who have questions about the Medicare program.
The publicly traded EHR and cloud healthcare IT infrastructure company confirmed in a filing with the U.S. Securities and Exchange Commission that hackers were able to breach its network in March for roughly eight hours, gaining partial access to patient record stores. The incident is being investigated.
The policy shift by Aetna to reimburse hospital stays of fewer than five days as outpatient observation encounters went into effect in January. The insurer implemented the policy to reduce friction with hospitals that previously had to seek approval for inpatient reimbursement, which was often denied. Jefferson Health is challenging the changes in court.
On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.
The cloud infrastructure company said in a recent investor meeting that its heavy spending on AI has been complicated by the global GPU and CPU shortage. Some 10,000 workers have reportedly been laid off, but the true number is unknown.
However, an analysis from research firm PitchBook suggests a rebound could be on the horizon, as investors shift their gaze to specialty care services.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
Oral decongestants containing phenylephrine were found not to be effective. However, nasal sprays of the same drug are not subject to the FDA’s proposed order.
Samantha Maltin, a former marketing executive at Sesame Workshop, will now lead branding and public outreach initiatives at St. Jude Children's Research Hospital.